Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Sep;48(12):2085-2095.
doi: 10.1017/S0033291718001253. Epub 2018 May 28.

Perimenstrual Exacerbation of Symptoms in Borderline Personality Disorder: Evidence From Multilevel Models and the Carolina Premenstrual Assessment Scoring System

Affiliations
Free PMC article

Perimenstrual Exacerbation of Symptoms in Borderline Personality Disorder: Evidence From Multilevel Models and the Carolina Premenstrual Assessment Scoring System

Tory A Eisenlohr-Moul et al. Psychol Med. .
Free PMC article

Erratum in

Abstract

Background: Individuals with a borderline personality disorder (BPD) suffer from a constellation of rapidly shifting emotional, interpersonal, and behavioral symptoms. The menstrual cycle may contribute to symptom instability among females with this disorder.

Methods: Fifteen healthy, unmedicated females with BPD and without dysmenorrhea reported daily symptoms across 35 days. Urine luteinizing hormone and salivary progesterone (P4) were used to confirm ovulation and cycle phase. Cyclical worsening of symptoms was evaluated using (1) phase contrasts in multilevel models and (2) the Carolina Premenstrual Assessment Scoring System (C-PASS), a protocol for evaluating clinically significant cycle effects on symptoms.

Results: Most symptoms demonstrated midluteal worsening, a perimenstrual peak, and resolution of symptoms in the follicular or ovulatory phase. Post-hoc correlations with person-centered progesterone revealed negative correlations with most symptoms. Depressive symptoms showed an unexpected delayed pattern in which baseline levels of symptoms were observed in the ovulatory and midluteal phases, and exacerbations were observed during both the perimenstrual and follicular phases. The majority of participants met C-PASS criteria for clinically significant (⩾30%) symptom exacerbation. All participants met the emotional instability criterion of BPD, and no participant met DSM-5 criteria for premenstrual dysphoric disorder (PMDD).

Conclusions: Females with BPD may be at elevated risk for perimenstrual worsening of emotional symptoms. Longitudinal studies with fine-grained hormonal measurement as well as hormonal experiments are needed to determine the pathophysiology of perimenstrual exacerbation in BPD.

Keywords: Borderline personality disorder; menstrual cycle; ovarian steroid hormones.

Conflict of interest statement

Conflicts of Interest: None.

Figures

Figure 1.
Figure 1.
Person-Standardized Progesterone (dashed line) and Interpersonal Conflict Across Menstrual Cycle Day (Panel A) and Person-Standardized Interpersonal Conflict Across Cycle Phase (Panel B) in 15 People with BPD.
Figure 2.
Figure 2.
Person-Standardized Progesterone (dashed line) and Felt Invalidation Across Menstrual Cycle Day (Panel A) and Person-Standardized Felt Invalidation Across Cycle Phase (Panel B) in 15 People with BPD.
Figure 3.
Figure 3.
Person-Standardized Progesterone (dashed line) and Hopelessness Across Menstrual Cycle Day (Panel A) and Person-Standardized Hopelessness Across Cycle Phase (Panel B) in 15 People with BPD.

Similar articles

See all similar articles

Cited by 4 articles

Publication types

Feedback